NVCR Relative Valuation
NVCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVCR is overvalued; if below, it's undervalued.
Historical Valuation
Novocure Ltd (NVCR) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.90. The fair price of Novocure Ltd (NVCR) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：11.76
Fair
-8.00
PE
1Y
3Y
5Y
Trailing
Forward
-8.24
EV/EBITDA
Novocure Ltd. (NVCR) has a current EV/EBITDA of -8.24. The 5-year average EV/EBITDA is -121.39. The thresholds are as follows: Strongly Undervalued below -806.47, Undervalued between -806.47 and -463.93, Fairly Valued between 221.15 and -463.93, Overvalued between 221.15 and 563.69, and Strongly Overvalued above 563.69. The current Forward EV/EBITDA of -8.24 falls within the Historic Trend Line -Fairly Valued range.
-6.70
EV/EBIT
Novocure Ltd. (NVCR) has a current EV/EBIT of -6.70. The 5-year average EV/EBIT is -55.35. The thresholds are as follows: Strongly Undervalued below -644.51, Undervalued between -644.51 and -349.93, Fairly Valued between 239.23 and -349.93, Overvalued between 239.23 and 533.81, and Strongly Overvalued above 533.81. The current Forward EV/EBIT of -6.70 falls within the Historic Trend Line -Fairly Valued range.
1.93
PS
Novocure Ltd. (NVCR) has a current PS of 1.93. The 5-year average PS is 11.90. The thresholds are as follows: Strongly Undervalued below -8.17, Undervalued between -8.17 and 1.86, Fairly Valued between 21.94 and 1.86, Overvalued between 21.94 and 31.98, and Strongly Overvalued above 31.98. The current Forward PS of 1.93 falls within the Historic Trend Line -Fairly Valued range.
-1322.51
P/OCF
Novocure Ltd. (NVCR) has a current P/OCF of -1322.51. The 5-year average P/OCF is -3.86. The thresholds are as follows: Strongly Undervalued below -1103.43, Undervalued between -1103.43 and -553.64, Fairly Valued between 545.92 and -553.64, Overvalued between 545.92 and 1095.70, and Strongly Overvalued above 1095.70. The current Forward P/OCF of -1322.51 falls within the Strongly Undervalued range.
-28.06
P/FCF
Novocure Ltd. (NVCR) has a current P/FCF of -28.06. The 5-year average P/FCF is 106.01. The thresholds are as follows: Strongly Undervalued below -283.01, Undervalued between -283.01 and -88.50, Fairly Valued between 300.52 and -88.50, Overvalued between 300.52 and 495.03, and Strongly Overvalued above 495.03. The current Forward P/FCF of -28.06 falls within the Historic Trend Line -Fairly Valued range.
Novocure Ltd (NVCR) has a current Price-to-Book (P/B) ratio of 3.86. Compared to its 3-year average P/B ratio of 7.59 , the current P/B ratio is approximately -49.17% higher. Relative to its 5-year average P/B ratio of 16.42, the current P/B ratio is about -76.50% higher. Novocure Ltd (NVCR) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -3.83%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -2.06% , the current FCF yield is about -100.00% lower.
3.86
P/B
Median3y
7.59
Median5y
16.42
-4.93
FCF Yield
Median3y
-3.83
Median5y
-2.06
Competitors Valuation Multiple
The average P/S ratio for NVCR's competitors is , providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 7.81%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NVCR decreased by 60.54% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -19.71 to -22.29.
The secondary factor is the Revenue Growth, contributed 7.81%to the performance.
Overall, the performance of NVCR in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Novocure Ltd (NVCR) currently overvalued or undervalued?
What is Novocure Ltd (NVCR) fair value?
How does NVCR's valuation metrics compare to the industry average?
What is the current P/B ratio for Novocure Ltd (NVCR) as of Dec 05 2025?
What is the current FCF Yield for Novocure Ltd (NVCR) as of Dec 05 2025?
What is the current Forward P/E ratio for Novocure Ltd (NVCR) as of Dec 05 2025?